OC
SPPI

Oppenheimer & Co’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Oppenheimer & Co’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-13,455
Closed -$80K – 1389
2015
Q3 		$80K Buy
+13,455
New +$93.4K ﹤0.01% 1278
2015
Q2 		– Sell
-16,102
Closed -$98K – 1573
2015
Q1 		$98K Buy
+16,102
New +$107K ﹤0.01% 1412

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Oppenheimer & Co's SPPI Position: Q4 2015 in Review

Oppenheimer & Co sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2015, closing a stake of 13,455 shares — an estimated $80K sold.

Oppenheimer & Co first reported a position in SPPI in Q1 2015 and held it in 2 quarters. The position peaked at $98K in Q1 2015. 146 funds tracked by Wall St. Rank hold SPPI as of Q4 2015.

  • Oppenheimer & Co reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 13,455 Spectrum Pharmaceuticals Inc shares in Q4 2015, an estimated $80K.
  • Oppenheimer & Co first reported a position in Spectrum Pharmaceuticals Inc in Q1 2015 and held it in 2 quarters.
  • Oppenheimer & Co's Spectrum Pharmaceuticals Inc position peaked at $98K in Q1 2015.
  • 146 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.